-

SHAREHOLDER ALERT: Robbins LLP Announces that loanDepot, Inc. (LDI) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired loanDepot, Inc. (NYSE: LDI) pursuant to or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's February 2021 initial public offering ("IPO"). The complaint seeks remedies under the Securities Act of 1933. loanDepot is an independent retail mortgage lender that provides residential loans, refinance loans, and personal loan products nationwide.

If you suffered a loss due to loanDepot, Inc.'s misconduct, click here.

loanDepot, Inc. (LDI) Materially Misrepresented its Business Prospects in Connection with its IPO

According to the complaint, the Registration Statement in connection with the Company's IPO stated that the Company's "innovative technology" had allowed it to realize significantly increased revenues and profitability and rapidly increasing loan origination growth. The Prospectus stated that loanDepot had significantly increased its market share and was well-positioned to protect and grow that market share through its proprietary "platform and technology," which supposedly gave loanDepot a "significant financial advantage."

However, these statements were false and misleading. Specifically, defendants failed to disclose to investors that: (i) the Company's refinance originations had already declined substantially at the time of the IPO due to industry over-capacity and increased competition; (ii) the Company's gain-on-sale margins had already declined substantially at the time of the IPO; and (iii) as a result, the Company's revenue and growth would be negatively impacted.

On August 3, 2021, loanDepot announced disappointing Q2 2021 results. In so doing, the founder, Chairman, and CEO admitted that everything about loanDepot's business is "highly predictable" and thus loanDepot had visibility at the time of the IPO as to where its business was and was going. By August 17, 2021, loanDepot's stock had declined to $8.07 per share, a more than 42% decline from the IPO price.

If you purchased shares of loanDepot, Inc. (LDI) securities in connection with the Company's February 2021 IPO, you have until November 8, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against loanDepot, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:LDI

Release Summary
loanDepot, Inc. (LDI) Materially Misrepresented its Business Prospects in Connection with its IPO
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the SES AI Corporation Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired SES AI Corporation (NYSE: SES) securities between January 29, 2025 and March 4, 2026. SES claims to be a "leading developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (“Li-Metal”) and Lithium-ion (“Li-ion”) rechargeable battery technologies and battery materials for Energy Storage Systems (“ESS”), Urban Air Mobility (“UAM”)...

Investor Notice: Robbins LLP Informs Investors of the Regencell Bioscience Holdings Limited Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

Investor Notice: Robbins LLP Informs Investors of the Globant S.A. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Globant S.A. (NYSE: GLOB) common stock between February 15, 2024 and August 14, 2025. Globant is a Luxembourg-incorporated international technology company that provides digital consulting and related services. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LL...
Back to Newsroom